-5%
Ibrutinib is used for the treatment of blood cancers like mantle cell lymphoma, chronic lymphocytic leukemia (CLL), and lymphoplasmacytic lymphoma.
Ibrucent 140mg Capsule is employed for the treatment of various conditions:
- Chronic Lymphocytic Leukemia: Used to treat chronic lymphocytic leukemia, a type of blood cancer affecting lymphocytes.
- Mantle Cell Lymphoma: Administered to individuals with mantle cell lymphoma, a lymph node cancer, who haven’t responded well to prior therapy.
- Waldenstrom’s Macroglobulinemia: Used in the treatment of Waldenstrom’s macroglobulinemia, a cancer originating from bone marrow lymphocytes, for patients with inadequate response to previous therapy.
- Marginal Zone Lymphoma: Prescribed for marginal zone lymphoma patients who have undergone specific chemotherapy and still require treatment.
- Chronic Graft-Versus-Host Disease (cGVHD): Utilized to address chronic graft-versus-host disease in patients who haven’t responded sufficiently to prior systemic therapies.
